期刊
JOURNAL OF PATHOLOGY
卷 223, 期 2, 页码 230-240出版社
WILEY
DOI: 10.1002/path.2788
关键词
lung cancer; signal transduction pathway; gene mutation; protein kinase; targeted therapy; genetic analysis; sequencing; gene fusion; gene rearrangement
资金
- Xcovery
Knowledge of tumour mutation status has become increasingly important for the prioritization of targeted therapies for cancer. We review here the major known 'driver' mutations with therapeutic relevance in non-small cell lung cancer. We also discuss a variety of methods now being employed in molecular diagnostic laboratories to detect genetic alterations in lung tumours. A genetically-informed approach to lung cancer medicine is rapidly becoming the standard of care worldwide and should lead to improved outcomes for patients. Copyright (C) 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据